Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease

被引：0
|
作者：
Christoph Anthoni
Rudolf B. Mennigen
Emile J. M. Rijcken
Mike G. Laukötter
Hans-Ullrich Spiegel
Norbert Senninger
Guido Schürmann
Christian F. Krieglstein
机构：
[1] Westfalian Wilhelm's University,Department of General Surgery
[2] Klinikum Itzehoe,Department of Surgery
[3] LSU Health Science Center,Department of Molecular and Cellular Physiology
来源：
International Journal of Colorectal Disease | 2006年 / 21卷
关键词：
Bosentan; Endothelins; Inflammatory bowel disease; Dextran sodium sulphate; Chronic colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：409 / 418
页数：9
相关论文
共 50 条
  • [21] The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis
    Kuang, Hong-Yu
    Wu, Yu-Hao
    Yi, Qi-Jian
    Tian, Jie
    Wu, Chun
    Shou, We Nian
    Lu, Tie-Wei
    MEDICINE, 2018, 97 (10)
  • [22] Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease
    Prados, Maria E.
    Garcia-Martin, Adela
    Unciti-Broceta, Juan D.
    Palomares, Belen
    Collado, Juan A.
    Minassi, Alberto
    Calzado, Marco A.
    Appendino, Giovanni
    Munoz, Eduardo
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (07) : 1124 - 1138
  • [23] Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease
    María E. Prados
    Adela García-Martín
    Juan D. Unciti-Broceta
    Belén Palomares
    Juan A. Collado
    Alberto Minassi
    Marco A. Calzado
    Giovanni Appendino
    Eduardo Muñoz
    Acta Pharmacologica Sinica, 2021, 42 : 1124 - 1138
  • [24] Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease
    Punekar, Salman
    Zak, Samantha
    Kalter, Valerie G.
    Dobransky, Larissa
    Punekar, Imran
    Lawler, Jack W.
    Gutierrez, Linda S.
    PATHOBIOLOGY, 2008, 75 (01) : 9 - 21
  • [25] Gut lavage IgG and interleukin 1 receptor antagonist: Interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease
    Troncone, R
    Caputo, N
    Campanozzi, A
    Cucciardi, M
    Esposito, V
    Russo, R
    DeVizia, B
    Greco, L
    Cucchiara, S
    GUT, 1997, 41 (01) : 60 - 65
  • [26] The Colonic Vitamin D Receptor and Inflammatory Bowel Disease: No Correlation to Histologic or Endoscopic Inflammation
    Bagger-Jorgensen, Harald
    Thomsen, Christian
    Borrisholt, Martine
    Wanders, Alkwin
    Sjoberg, Klas
    APMIS, 2025, 133 (01)
  • [27] Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease
    Arthur, LG
    Schwartz, MZ
    Kuenzler, KA
    Birbe, R
    JOURNAL OF PEDIATRIC SURGERY, 2004, 39 (02) : 139 - 143
  • [28] Metallothionein overexpression does not protect against inflammatory bowel disease in a murine colitis model
    Oz, HS
    Chen, T
    de Villiers, WJS
    McClain, CJ
    MEDICAL SCIENCE MONITOR, 2005, 11 (03): : BR69 - BR73
  • [29] CHARACTERIZATION OF CIRCULATING INTERLEUKIN-1 RECEPTOR ANTAGONIST EXPRESSION IN CHILDREN WITH INFLAMMATORY BOWEL-DISEASE
    HYAMS, JS
    FITZGERALD, JE
    WYZGA, N
    TREEM, WR
    JUSTINICH, CJ
    KREUTZER, DL
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (09) : 1893 - 1899
  • [30] Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease
    Maeda, Shingo
    Ohno, Koichi
    Nakamura, Kenji
    Uchida, Kazuyuki
    Nakashima, Ko
    Fukushima, Kenjiro
    Tsukamoto, Atsushi
    Goto-Koshino, Yuko
    Fujino, Yasuhito
    Tsujimoto, Hajime
    VETERINARY JOURNAL, 2012, 194 (01) : 66 - 70
12345